Guess which ASX 300 healthcare share is lifting off on $25 million news

The ASX 300 healthcare share is grabbing investor interest on Thursday. Let's see why.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Regis Healthcare's share price increased by 0.8% to $8.01 after announcing a divestment deal with Ozcare.
  • The company is selling two aged care facilities in Far North Queensland, aiming for a $25 million pre-tax gain recognised in FY 2026.
  • The divestment aligns with Regis' strategy to optimise its portfolio, while enhancing Ozcare’s presence.

S&P/ASX 300 Index (ASX: XKO) healthcare share Regis Healthcare Ltd (ASX: REG) is marching higher today.

Shares in the residential aged care provider closed yesterday trading for $7.95. In morning trade on Thursday, shares are changing hands for $8.01 apiece, up 0.8%.

For some context, the ASX 300 is up 0.4% at this same time.

Here's what's catching investor interest today.

Excited elderly woman on a swing.

Image source: Getty Images

ASX 300 healthcare share lifts on divestment news

The Regis Healthcare share price is pushing higher after the company announced that it has entered into agreements with not for profit aged care and health services provider Ozcare to sell two residential aged care homes.

The two assets are located at Ayr and Home Hill, both in Far North Queensland. Together, the two aged care facilities have 156 operational beds.

The ASX 300 healthcare stock expects the sale to bring in a one-off pre-tax gain on sale of approximately $25 million. The company said this gain will be recognised in its FY 2026 financial results.

Regis Healthcare expects the transaction to be complete by 1 March, subject to customary conditions.

What did management say?

Commenting on the divestment that looks to be boosting the ASX 300 healthcare share today, Regis managing director and CEO Linda Mellors said, "The divestment aligns with Regis' strategy to optimise its national portfolio and recycle capital to support investment in high-demand, premium locations where we can deliver the greatest impact."

Mellors continued:

We will work closely with Ozcare to ensure a smooth and respectful transition for residents, families, and staff, and to support continuity of care in Far North Queensland.

Ozcare CEO Kevin Mercer added:

We are delighted to welcome Ayr and Home Hill into the Ozcare family. These homes have a strong reputation for delivering quality care and supporting their local communities, which aligns perfectly with our mission to provide compassionate, person-centred services.

This acquisition strengthens our presence in North Queensland and ensures continuity of care for residents, families, and staff. We look forward to building on the excellent foundations laid by Regis and continuing to enhance the wellbeing of those we serve.

What's been happening with the ASX 300 healthcare share?

With today's intraday increase factored in, Regis Health Care shares are up 33% in 2025.

The ASX 300 healthcare share hit an all-time closing high of $9.22 on 19 September.

Shares then crashed 26.3% the following trading day, 22 September.

That sell-off followed news that the Australian government's residential aged care funding boost of 4.7% was less than Regis had expected, which comes amid increased staffing costs.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Young businesswoman sitting in kitchen and working on laptop.
Healthcare Shares

Up 15% in a week, is it too late to buy rebounding CSL shares?

CSL shares trade on roughly 13 times forecast FY26 earnings and offer a good dividend yield.

Read more »

A woman leans forward with her hand behind her ear, as if trying to hear information.
Broker Notes

Down 60%, are Cochlear shares now a bargain buy?

A leading analyst provides his outlook for Cochlear’s beaten-down shares.

Read more »

Young woman thinking with laptop open.
Healthcare Shares

Why are Sigma Healthcare shares in the spotlight this week?

Is the latest sell-off overdone?

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Is it time to get greedy with Pro Medicus shares?

The company was swept up in the huge sector-wide downturn in late 2025 and early 2026 as investors turned their…

Read more »

Young doctor raising arms in air with hands in fists celebrating a new development.
Healthcare Shares

Prediction: I think Telix shares could double in value in 2026. Here's why

The biopharmaceutical company's shares dipped to a three-year low in February, but have now rebounded strongly.

Read more »

A woman reclines in a comfortable chair while she donates blood holding a pumping toy in one hand and giving the thumbs up in the other as she is attached to a medical machine to collect her blood donation.
Healthcare Shares

How much does UBS think CSL will bounce back?

If the worst is over, what's the upside for the shares?

Read more »

Woman with long hair smiles for the camera.
Healthcare Shares

Why I'd buy CSL shares while sentiment is weak

The market no longer treats this ASX healthcare giant as flawless, and that may make the investment case more interesting.

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Is this exciting healthcare stock a buy, hold or sell after rocketing 16% yesterday?

Can this soaring stock keep rising?

Read more »